Sofinnova Investments
Menlo Park, Californiasofinnova.com
Overview
Sofinnova Investments is a healthcare investment firm that partners with entrepreneurs to fund and build innovative biopharmaceutical companies across all stages of development.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Quanta Therapeutics | Jun 2026 | Series D | Co-investor |
| City Therapeutics | Jun 2026 | Series B | Lead |
| Avenzo Therapeutics | Jun 2026 | Private Placement | Co-investor |
| Coultreon Biopharma | Apr 2026 | Series A | Lead |
| Aeovian Pharmaceuticals | Dec 2025 | Series B | Co-investor |
Key People
James H.
Managing Partner
Eric Delbridge
General Partner
Maha Katabi
General Partner
Sarah Bhagat
General Partner
Goro Takeda
Venture Partner
Aneal Tenjarla
Associate Portfolio Manager, Partner
Chris Carpenter
Executive Partner
Jakob Dupont
Executive Partner
Jonathan Leff
Executive Partner
Lars Ekman
Excecutive Partner
Perry Nisen
Executive Partner
Remy Aubert
Partner
Nathalie Auber
Partner And CFO
Nick Lenard
Healthcare Investor
Peng Li
Healthcare Investor
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
